# FDA Inspection 1008957 - Marlinz Pharma, LLC - February 09, 2017

Source: https://www.keypedia.com/records/fda_inspections/marlinz-pharma-llc/8598920e-c38a-461c-be40-87fa2ffa741b
Source feed: FDA_Inspections

> FDA Inspection 1008957 for Marlinz Pharma, LLC on February 09, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008957
- Company Name: Marlinz Pharma, LLC
- Inspection Date: 2017-02-09
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1169023 - 2022-05-04](https://www.keypedia.com/records/fda_inspections/marlinz-pharma-llc/4b5ea71f-b7cf-4f34-b34b-5fea311505bb)

Company: https://www.keypedia.com/companies/marlinz-pharma-llc/66897e87-8f53-4e28-86b4-e6db39fd3dce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c